Literature DB >> 21832166

Mucosa-associated epithelial chemokine/CCL28 expression in the uterus attracts CCR10+ IgA plasma cells following mucosal vaccination via estrogen control.

Hye-Ran Cha1, Hyun-Jeong Ko, Eun-Do Kim, Sun-Young Chang, Sang-Uk Seo, Nicolas Cuburu, Sangryeol Ryu, Sunghoon Kim, Mi-Na Kweon.   

Abstract

Previous studies demonstrated cross talk between mucosal and reproductive organs during secretory IgA Ab induction. In this study, we aimed to clarify the underlying mechanisms of this cross talk. We found significantly higher titers of Ag-specific secretory IgA Ab in the vaginal wash after mucosal vaccination by both the intranasal (i.n.) and the intravaginal routes but not by the s.c. route. Interestingly, Ag-specific IgA Ab-secreting cells (ASCs) were found mainly in the uterus but not in the cervix and vaginal canal after i.n. vaccination. The fact that most Ag-specific IgA ASCs isolated from the uteri of vaccinated mice migrated toward mucosa-associated epithelial chemokine (MEC)/CCL28 suggests dominant expression of CCR10 on the IgA ASCs. Further, IgA ASCs in the uteri of vaccinated mice were reduced drastically in mice treated with neutralizing anti-MEC/CCL28 Ab. Most intriguingly, the female sex hormone estrogen directly regulated MEC/CCL28 expression and was augmented by i.n. vaccination with cholera toxin or stimulators for innate immunity. Further, blockage of estrogen function in the uterus by oral administration of the estrogen antagonist raloxifene significantly inhibited migration of Ag-specific IgA ASCs after i.n. vaccination with OVA plus cholera toxin. Taken together, these data strongly suggest that CCR10(+) IgA ASCs induced by mucosal vaccination via the i.n. route migrate into the uterus in a MEC/CCL28-dependent manner and that estrogen might have a crucial role in the protection against genital infection by regulating MEC/CCL28 expression in the uterus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832166     DOI: 10.4049/jimmunol.1100402

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  CCR10 and its ligands in regulation of epithelial immunity and diseases.

Authors:  Na Xiong; Yaoyao Fu; Shaomin Hu; Mingcan Xia; Jie Yang
Journal:  Protein Cell       Date:  2012-06-08       Impact factor: 14.870

2.  Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells.

Authors:  C Hervouet; C Luci; S Bekri; T Juhel; F Bihl; V M Braud; C Czerkinsky; F Anjuère
Journal:  Mucosal Immunol       Date:  2013-06-26       Impact factor: 7.313

Review 3.  Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Authors:  Mevyn Nizard; Mariana O Diniz; Helene Roussel; Thi Tran; Luis Cs Ferreira; Cecile Badoual; Eric Tartour
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

5.  CCL28 Is Involved in Mucosal IgA Responses, Olfaction, and Resistance to Enteric Infections.

Authors:  Amanda M Burkhardt; Araceli Perez-Lopez; Irina Ushach; Jovani Catalan-Dibene; Sean-Paul Nuccio; Lawton K Chung; Marcela Hernandez-Ruiz; Christina Carnevale; Manuela Raffatellu; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2019-03-11       Impact factor: 2.607

6.  Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses.

Authors:  Teena Mohan; Jongrok Kim; Zachary Berman; Shelly Wang; Richard W Compans; Bao-Zhong Wang
Journal:  J Control Release       Date:  2016-05-10       Impact factor: 9.776

7.  A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains.

Authors:  Shifeng Wang; Huoying Shi; Yuhua Li; Zhaoxing Shi; Xin Zhang; Chang-Ho Baek; Tabor Mothershead; Roy Curtiss
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

8.  Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.

Authors:  John G Facciponte; Stefano Ugel; Francesco De Sanctis; Chunsheng Li; Liping Wang; Gautham Nair; Sandy Sehgal; Arjun Raj; Efthymia Matthaiou; George Coukos; Andrea Facciabene
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

9.  A role for the CCR5-CCL5 interaction in the preferential migration of HSV-2-specific effector cells to the vaginal mucosa upon nasal immunization.

Authors:  Sunyi Joo; Aldina Suwanto; Ayuko Sato; Rika Nakahashi-Ouchida; Hiromi Mori; Yohei Uchida; Shintaro Sato; Yosuke Kurashima; Yoshikazu Yuki; Kohtaro Fujihashi; Yasushi Kawaguchi; Hiroshi Kiyono
Journal:  Mucosal Immunol       Date:  2019-09-24       Impact factor: 7.313

10.  Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model.

Authors:  Aimee L Signarovitz; Heather J Ray; Jieh-Juen Yu; M N Guentzel; James P Chambers; Karl E Klose; Bernard P Arulanandam
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.